Image Source: AsiaOne
Junshi Biosciences Announces 2023 Full Year Financial Results and Provides Corporate Updates GlobeNewswire March 29, 2024 SHANGHAI, China, March 29, 2024 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences,” HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced its financial results for the full year of 2023 and provided corporate updates. FINANCIAL HIGHLIGHTS
Source: AsiaOne